• Treffer 7 von 9
Zurück zur Trefferliste

Plant-Based Production of Recombinant Plasmodium Surface Protein Pf38 and Evaluation of its Potential as a Vaccine Candidate

Zitieren Sie bitte immer diese URN: urn:nbn:de:bvb:20-opus-128221
  • Pf38 is a surface protein of the malarial parasite Plasmodium falciparum. In this study, we produced and purified recombinant Pf38 and a fusion protein composed of red fluorescent protein and Pf38 (RFP-Pf38) using a transient expression system in the plant Nicotiana benthamiana. To our knowledge, this is the first description of the production of recombinant Pf38. To verify the quality of the recombinant Pf38, plasma from semi-immune African donors was used to confirm specific binding to Pf38. ELISA measurements revealed that immune responsesPf38 is a surface protein of the malarial parasite Plasmodium falciparum. In this study, we produced and purified recombinant Pf38 and a fusion protein composed of red fluorescent protein and Pf38 (RFP-Pf38) using a transient expression system in the plant Nicotiana benthamiana. To our knowledge, this is the first description of the production of recombinant Pf38. To verify the quality of the recombinant Pf38, plasma from semi-immune African donors was used to confirm specific binding to Pf38. ELISA measurements revealed that immune responses to Pf38 in this African subset were comparable to reactivities to AMA-1 and \(MSP1_{19}\). Pf38 and RFP-Pf38 were successfully used to immunise mice, although titres from these mice were low (on average 1:11.000 and 1:39.000, respectively). In immune fluorescence assays, the purified IgG fraction from the sera of immunised mice recognised Pf38 on the surface of schizonts, gametocytes, macrogametes and zygotes, but not sporozoites. Growth inhibition assays using \(\alpha Pf38\) antibodies demonstrated strong inhibition \((\geq 60 \% ) \) of the growth of blood-stage P. falciparum. The development of zygotes was also effectively inhibited by \(\alpha Pf38\) antibodies, as determined by the zygote development assay. Collectively, these results suggest that Pf38 is an interesting candidate for the development of a malaria vaccine.zeige mehrzeige weniger

Volltext Dateien herunterladen

Metadaten exportieren

Weitere Dienste

Teilen auf Twitter Suche bei Google Scholar Statistik - Anzahl der Zugriffe auf das Dokument
Metadaten
Autor(en): Tatjana Feller, Pascal Thom, Natalie Koch, Holger Spiegel, Otchere Addai-Mensah, Rainer Fischer, Andreas Reimann, Gabriele Pradel, Rolf Fendel, Stefan Schillberg, Matthias Scheuermayer, Helga Schinkel
URN:urn:nbn:de:bvb:20-opus-128221
Dokumentart:Artikel / Aufsatz in einer Zeitschrift
Institute der Universität:Medizinische Fakultät / Institut für Molekulare Infektionsbiologie
Sprache der Veröffentlichung:Englisch
Titel des übergeordneten Werkes / der Zeitschrift (Englisch):PLOS ONE
ISSN:1932-6203
Erscheinungsjahr:2013
Band / Jahrgang:8
Heft / Ausgabe:11
Seitenangabe:e79920
Originalveröffentlichung / Quelle:PLoS ONE 8(11): e79920. doi:10.1371/journal.pone.0079920
DOI:https://doi.org/10.1371/journal.pone.0079920
Allgemeine fachliche Zuordnung (DDC-Klassifikation):6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 615 Pharmakologie, Therapeutik
Freie Schlagwort(e):N-glycans; antibodies; antigen; balancing selection; expression; falciparum; identification; malaria vaccine; tobacco; transmission
Datum der Freischaltung:30.03.2016
Lizenz (Deutsch):License LogoCC BY: Creative-Commons-Lizenz: Namensnennung